Study of Multiple Doses of Saxagliptin (BMS-477118)

Clinical trial NCT00950599 · COMPLETED

Trial details

NCT number: NCT00950599
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2003-05-01
Primary completion: 2004-05-01
Enrollment: 423

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.